Marinomed Biotech Management

Management criteria checks 2/4

Marinomed Biotech's CEO is Andreas Grassauer, appointed in Apr 2006, has a tenure of 18.08 years. total yearly compensation is €307.20K, comprised of 72.3% salary and 27.7% bonuses, including company stock and options. directly owns 7.9% of the company’s shares, worth €2.08M. The average tenure of the management team and the board of directors is 18.1 years and 1.9 years respectively.

Key information

Andreas Grassauer

Chief executive officer

€307.2k

Total compensation

CEO salary percentage72.3%
CEO tenure18.1yrs
CEO ownership7.9%
Management average tenure18.1yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

Marinomed Biotech AG (VIE:MARI) Could Be Riskier Than It Looks

Feb 03
Marinomed Biotech AG (VIE:MARI) Could Be Riskier Than It Looks

Marinomed Biotech AG (VIE:MARI) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Apr 22
Marinomed Biotech AG (VIE:MARI) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Marinomed Biotech AG's (VIE:MARI) Analyst Just Slashed This Year's Estimates

Sep 22
Marinomed Biotech AG's (VIE:MARI) Analyst Just Slashed This Year's Estimates

CEO Compensation Analysis

How has Andreas Grassauer's remuneration changed compared to Marinomed Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-€7m

Sep 30 2023n/an/a

-€6m

Jun 30 2023n/an/a

-€6m

Mar 31 2023n/an/a

-€7m

Dec 31 2022€307k€222k

-€6m

Sep 30 2022n/an/a

-€5m

Jun 30 2022n/an/a

-€5m

Mar 31 2022n/an/a

-€6m

Dec 31 2021€300k€200k

-€6m

Sep 30 2021n/an/a

-€8m

Jun 30 2021n/an/a

-€7m

Mar 31 2021n/an/a

-€7m

Dec 31 2020€324k€200k

-€6m

Sep 30 2020n/an/a

-€6m

Jun 30 2020n/an/a

-€6m

Mar 31 2020n/an/a

-€6m

Dec 31 2019€440k€200k

-€7m

Sep 30 2019n/an/a

-€14m

Jun 30 2019n/an/a

-€15m

Mar 31 2019n/an/a

-€14m

Dec 31 2018€177k€177k

-€12m

Compensation vs Market: Andreas's total compensation ($USD330.96K) is about average for companies of similar size in the Austrian market ($USD304.20K).

Compensation vs Earnings: Andreas's compensation has increased whilst the company is unprofitable.


CEO

Andreas Grassauer (54 yo)

18.1yrs

Tenure

€307,200

Compensation

Mr. Andreas Grassauer, PhD, is a Co-Founder of Marinomed Biotechnology GmbH in 2006 and serves as its Chairman of Management Board and has been Chief Executive Officer since 2006. Mr. Grassauer has co-foun...


Leadership Team

NamePositionTenureCompensationOwnership
Andreas Grassauer
Co-Founder18.1yrs€307.20k7.9%
€ 2.1m
Eva Prieschl-Grassauer
Co-Founder18.3yrs€299.60k7.9%
€ 2.1m
Pascal Schmidt
CFO & Member of Management Board5.8yrs€311.70kno data
Stephanie Kniep
Head of Investor Relationsno datano datano data

18.1yrs

Average Tenure

54yo

Average Age

Experienced Management: MARI's management team is seasoned and experienced (18.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Simon Nebel
Independent Chairman of Supervisory Board6.9yrs€65.30kno data
Brigitte Ederer
Independent Vice Chairwoman of the Supervisory Board5.5yrs€20.00kno data
Balamurali Ambati
Member of Scientific Advisory Boardno datano datano data
Talin Barisani
Member of Scientific Advisory Boardno datano datano data
Julian Crane
Member of Scientific Advisory Boardno datano datano data
Ron Eccles
Member of Scientific Advisory Boardno datano datano data
Elisabeth Lackner
Independent Member of Supervisory Board1.9yrs€7.50kno data
Ulrich Kinzel
Independent Member of Supervisory Board1.9yrs€10.00kno data
Eva Hofstadter-Thalmann
Member of Supervisory Boardless than a yearno datano data

1.9yrs

Average Tenure

58yo

Average Age

Experienced Board: MARI's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.